STUDIES OF PLATELET ADHERENCE TO OSTEOPONTIN
STUDIES OF PLATELET ADHERENCE TO OSTEOPONTIN
批准号:
6302561
负责人:
JEAN BENNETT
金额:
$26.44万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2001-03-31
关键词:
CD44 molecule actins atherosclerosis atherosclerotic plaque cell adhesion guanine nucleotide binding protein hemodynamics human subject integrins nuclear magnetic resonance spectroscopy osteopontin peptide analog peptide chemical synthesis phlebotomy platelet activation protein kinase protein structure function receptor binding receptor expression site directed mutagenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cell adhesion plays a prominent role in the initiation and evolution of
atherosclerosis. For example, platelet-matrix and platelet-platelet
adhesion are responsible for the ultimate events in the atherosclerotic
process, acute coronary occlusion and stroke. We have shown that
activated, but not resting, platelets adhere to osteopontin (OPN), a
component of the extracellular matrix of calcified atherosclerotic
plaques, but not of the normal arterial wall. Thus, platelet adherence
to OPN could be part of the process whereby platelets form thrombi on
disrupted atherosclerotic plaques. Platelet adherence to OPN is
predominantly mediated by the integrin alphavbeta3. Thus, alphavbeta3,
like alphaIIbbeta3, is present on the surface of resting platelets in an
inactive state and is activated by platelet agonists. A second potential
receptor for OPN on platelets is CD44. CD44 is a receptor for hyaluronic
acid on many cells and has been reported to interact with OPN in a
cation and RGD-independent manner. The goal of this project is to
understand the structural basis for the interaction of OPN with
platelet various receptors. In Specific Aim 1, we will use in vitro
mutagenesis to exchange selected segments of alphav and alphaIIb and
measure constitutive and agonist-stimulated integrin binding to purified
OPN. Studies will focus on the role of cytoplasmic domain sequences and
RGD-peptide cross-linking sites. In addition, studies of the role of
CD44 in platelet adhesion to OPN will be performed. In Specific Aim 2,
we will identify signaling pathways that activate alphavbeta3. Proposed
experiments will focus on the role of protein and lipid kinases, the
actin cytoskeleton, and members of the Rho family of small GTP-binding
proteins in regulating alphavbeta3 ligand binding activity. In Specific
Aim 3, we will study the structural basis for the recognition of matrix
proteins by alphavbeta3. The features of OPN required for its
recognition by alphav-containing integrins, as well as the binding
affinities of various OPN fragments for alphavbeta3 will be determined.
Simple and complex flow systems will be used to study the ability of OPN
to support the adherence of both activated and unactivated platelets in
the presence of shear stress. Lastly, we determine the structural and
dynamic properties of various OPN fragment by NMR methods and the
information derived for these studies will be used to synthesize
constrained alphavbeta3 peptides and peptidomimetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An Inducible System for Gene Delivery
-
批准号:9012821
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2015
-
负责人:JEAN BENNETT
-
依托单位:
An Inducible System for Gene Delivery
-
批准号:8816191
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2015
-
负责人:JEAN BENNETT
-
依托单位:
Broad Spectrum Molecular Therapy for Blinding Retina Disorders
-
批准号:8144057
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2011
-
负责人:JEAN BENNETT
-
依托单位:
Broad Spectrum Molecular Therapy for Blinding Retina Disorders
-
批准号:8906870
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2011
-
负责人:JEAN BENNETT
-
依托单位:
Broad Spectrum Molecular Therapy for Blinding Retina Disorders
-
批准号:8536302
-
项目类别:
-
资助金额:$77.48万
-
财政年份:2011
-
负责人:JEAN BENNETT
-
依托单位:
Broad Spectrum Molecular Therapy for Blinding Retina Disorders
-
批准号:8337689
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2011
-
负责人:JEAN BENNETT
-
依托单位:
Broad Spectrum Molecular Therapy for Blinding Retina Disorders
-
批准号:8711469
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2011
-
负责人:JEAN BENNETT
-
依托单位:
Gene Therapy for Usher Syndrome (USH1C)
-
批准号:7454119
-
项目类别:
-
资助金额:$19.43万
-
财政年份:2007
-
负责人:JEAN BENNETT
-
依托单位:
Gene Therapy for Usher Syndrome (USH1C)
-
批准号:7313819
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2007
-
负责人:JEAN BENNETT
-
依托单位:
AAV-mediated gene correction in retina
-
批准号:7018779
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2006
-
负责人:JEAN BENNETT
-
依托单位:
AAV-mediated gene correction in retina
-
批准号:7235613
-
项目类别:
-
资助金额:$7.83万
-
财政年份:2006
-
负责人:JEAN BENNETT
-
依托单位:
STUDIES OF PLATELET ADHERENCE TO OSTEOPONTIN
-
批准号:6591070
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2002
-
负责人:JEAN BENNETT
-
依托单位:
STUDIES OF PLATELET ADHERENCE TO OSTEOPONTIN
-
批准号:6449414
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2001
-
负责人:JEAN BENNETT
-
依托单位:
STUDIES OF PLATELET ADHERENCE TO OSTEOPONTIN
-
批准号:6111052
-
项目类别:
-
资助金额:$26.44万
-
财政年份:1999
-
负责人:JEAN BENNETT
-
依托单位:
ANIMAL MODELS FOR A HEREDITARY MACULAR DEGENERATON
-
批准号:2605222
-
项目类别:
-
资助金额:$19.39万
-
财政年份:1998
-
负责人:JEAN BENNETT
-
依托单位:
Animal Model for a Hereditary Macular Degeneration
-
批准号:6665372
-
项目类别:
-
资助金额:$38.81万
-
财政年份:1998
-
负责人:JEAN BENNETT
-
依托单位:
Animal Model for a Hereditary Macular Degeneration
-
批准号:6518592
-
项目类别:
-
资助金额:$38.83万
-
财政年份:1998
-
负责人:JEAN BENNETT
-
依托单位:
Animal Model for a Hereditary Macular Degeneration
-
批准号:6333239
-
项目类别:
-
资助金额:$37.63万
-
财政年份:1998
-
负责人:JEAN BENNETT
-
依托单位:
Animal Model for a Hereditary Macular Degeneration
-
批准号:6765937
-
项目类别:
-
资助金额:$38.79万
-
财政年份:1998
-
负责人:JEAN BENNETT
-
依托单位:
ANIMAL MODELS FOR A HEREDITARY MACULAR DEGENERATON
-
批准号:6164721
-
项目类别:
-
资助金额:$22.26万
-
财政年份:1998
-
负责人:JEAN BENNETT
-
依托单位:
海外基金